The ownership structure of Ascendis Pharma (ASND) stock is a mix of institutional, retail, and individual investors. Approximately 33.09% of the company’s stock is owned by Institutional Investors, and 66.91% is owned by Public Companies and Individual Investors.

The ownership structure of Ascendis Pharma (ASND) stock is a mix of institutional, retail, and individual investors. Approximately 1.23% of the company’s stock is owned by Institutional Investors, 31.86% is owned by Insiders, and 66.91% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Sep 30, 2024	Farallon Capital Management, L.l.c.	xxxxxxxxxxxxx	$209034
Sep 30, 2024	Graham Capital Management, L.p.	xxxxxxxxxxxxx	$279508
Sep 30, 2024	Sivik Global Healthcare Llc	xxxxxxxxxxxxx	$1493100
Sep 30, 2024	Moore Capital Management Lp	xxxxxxxxxxxxx	$5972400

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
Peter Kolchinsky	9,710,428	Institution	16.12%	1,309,645,424
	2,302,340	Institution	3.82%	310,516,596
	1,515,509	Institution	2.52%	204,396,699
	1,500,636	Institution	2.49%	202,390,777
	1,306,042	Institution	2.17%	176,145,885
	1,247,536	Institution	2.07%	168,255,180
	1,063,909	Institution	1.77%	143,489,407
	949,425	Institution	1.58%	128,048,950
	907,331	Institution	1.51%	122,371,732
	670,000	Institution	1.11%	90,362,900

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
2,302,340	Institution	3.82%	310,516,596
1,515,509	Institution	2.52%	204,396,699
1,500,636	Institution	2.49%	202,390,777
1,306,042	Institution	2.17%	176,145,885
1,247,536	Institution	2.07%	168,255,180
1,063,909	Institution	1.77%	143,489,407
949,425	Institution	1.58%	128,048,950
907,331	Institution	1.51%	122,371,732
670,000	Institution	1.11%	90,362,900
658,550	Institution	1.09%	88,818,639

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Biotechnology ETF	300,137	Institution	0.50%	40,479,477
SPDR Portfolio Developed World ex-US ETF	32,097	Institution	0.05%	4,223,002
iShares NASDAQ US Biotechnology UCITS ETF	28,443	Institution	0.05%	3,742,246
T. Rowe Price Capital Appreciation Equity ETF	25,688	Institution	0.04%	3,379,770
American Century Focused Dynamic Growth ETF	21,048	Institution	0.03%	3,142,677
Harbor Health Care ETF	18,760	Institution	0.03%	2,530,161
Xtrackers S&P 500 Swap UCITS ETF	16,400	Institution	0.03%	2,157,748
Xtrackers S&P 500 Swap UCITS ETF 5C-EUR Hedged	16,400	Institution	0.03%	2,157,748
Fidelity Nasdaq Composite Index ETF	13,760	Institution	0.02%	1,872,461
Putnam Sustainable Future ETF	10,620	Institution	0.02%	1,585,672

FAQ

Who Owns Ascendis Pharma A/S (ASND)?

Currently, no data Available

What percentage of Ascendis Pharma A/S (ASND) stock is held by institutional investors?

According to the latest TipRanks data, approximately 0.22% of Ascendis Pharma A/S (ASND) stock is held by institutional investors.

What percentage of Ascendis Pharma A/S (ASND) stock is held by retail investors?

According to the latest TipRanks data, approximately 66.91% of Ascendis Pharma A/S (ASND) stock is held by retail investors.

Who owns the most shares of Ascendis Pharma A/S (ASND)?

Peter Kolchinsky owns the most shares of Ascendis Pharma A/S (ASND).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing